## **Core Concept**
In patients with chronic kidney disease (CKD), particularly those in stage 4, renal impairment significantly affects the metabolism and excretion of insulin and its analogs. The kidneys play a crucial role in insulin clearance. As kidney function declines, the clearance of insulin decreases, which can lead to a prolonged action of insulin.

## **Why the Correct Answer is Right**
In stage 4 CKD, the glomerular filtration rate (GFR) is severely reduced (15-29 mL/min/1.73 m²). Since the kidneys are responsible for about 50% of insulin clearance, a decrease in renal function results in reduced insulin clearance. This means that insulin can accumulate to higher levels and act for a longer duration than intended. Therefore, to avoid hypoglycemia, the dosage of insulin needs to be **reduced**. This adjustment helps in preventing episodes of hypoglycemia, which can be particularly dangerous in patients with CKD.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Increasing the insulin dose would be counterintuitive in a scenario where insulin clearance is decreased due to renal impairment. This could lead to increased risk of hypoglycemia.
- **Option B:** Maintaining the current dose without adjustment does not account for the decreased insulin clearance associated with reduced kidney function.
- **Option C:** While monitoring blood glucose levels closely is crucial, this option does not directly address the required adjustment in insulin dosage.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that patients with CKD, especially those on dialysis, may require a 25-50% reduction in insulin dose to prevent hypoglycemia due to decreased insulin clearance. Close monitoring of blood glucose levels is essential to guide these adjustments.

## **Correct Answer:** . Decrease the dose.